Published in Cancer Causes Control on May 01, 2003
Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr (2006) 2.41
Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect (2005) 1.97
Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol (2007) 1.96
Arsenic and cardiovascular disease. Toxicol Sci (2008) 1.90
Folate, Cobalamin, Cysteine, Homocysteine, and Arsenic Metabolism among Children in Bangladesh. Environ Health Perspect (2009) 1.83
Health effects of arsenic and chromium in drinking water: recent human findings. Annu Rev Public Health (2009) 1.81
Folic acid supplementation lowers blood arsenic. Am J Clin Nutr (2007) 1.70
Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ Health Perspect (2007) 1.69
Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina. Environ Health Perspect (2007) 1.66
Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study. Environ Health Perspect (2009) 1.63
Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic. Toxicol Sci (2008) 1.54
Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol (2009) 1.51
Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect (2007) 1.49
No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environ Health Perspect (2010) 1.48
Dietary intake and arsenic methylation in a U.S. population. Environ Health Perspect (2005) 1.47
Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect (2008) 1.45
Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina. Toxicol Appl Pharmacol (2010) 1.30
Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions. Environ Health Perspect (2006) 1.28
A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ Health Perspect (2013) 1.24
Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence. Environ Health (2014) 1.19
Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China. Environ Health Perspect (2007) 1.17
Nutritional status has marginal influence on the metabolism of inorganic arsenic in pregnant Bangladeshi women. Environ Health Perspect (2008) 1.16
Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect (2008) 1.16
Earth Abides Arsenic Biotransformations. Annu Rev Earth Planet Sci (2014) 1.15
Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA. Cancer Causes Control (2010) 1.13
Validity of spatial models of arsenic concentrations in private well water. Environ Res (2007) 1.11
Arsenic exposure from drinking water, arsenic methylation capacity, and carotid intima-media thickness in Bangladesh. Am J Epidemiol (2013) 1.05
The impact of diet and betel nut use on skin lesions associated with drinking-water arsenic in Pabna, Bangladesh. Environ Health Perspect (2006) 1.03
Respiratory cancer and inhaled inorganic arsenic in copper smelters workers: a linear relationship with cumulative exposure that increases with concentration. Environ Health Perspect (2008) 0.99
Impact of smoking and chewing tobacco on arsenic-induced skin lesions. Environ Health Perspect (2009) 0.99
Association of global DNA methylation and global DNA hydroxymethylation with metals and other exposures in human blood DNA samples. Environ Health Perspect (2014) 0.96
A pathway-based analysis of urinary arsenic metabolites and skin lesions. Am J Epidemiol (2011) 0.96
Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicity. J Toxicol (2012) 0.95
Arsenic exposure, arsenic metabolism, and incident diabetes in the strong heart study. Diabetes Care (2015) 0.93
Heritability and preliminary genome-wide linkage analysis of arsenic metabolites in urine. Environ Health Perspect (2013) 0.92
Association of genetic variation in cystathionine-beta-synthase and arsenic metabolism. Environ Res (2010) 0.88
A disulfide-bond cascade mechanism for arsenic(III) S-adenosylmethionine methyltransferase. Acta Crystallogr D Biol Crystallogr (2015) 0.87
Aquaglyceroporins: generalized metalloid channels. Biochim Biophys Acta (2013) 0.87
Relation between in Utero Arsenic Exposure and Birth Outcomes in a Cohort of Mothers and Their Newborns from New Hampshire. Environ Health Perspect (2016) 0.85
Suppression of urinary bladder urothelial carcinoma cell by the ethanol extract of pomegranate fruit through cell cycle arrest and apoptosis. BMC Complement Altern Med (2013) 0.84
Chronic Exposure to Arsenic and Markers of Cardiometabolic Risk: A Cross-Sectional Study in Chihuahua, Mexico. Environ Health Perspect (2015) 0.84
Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study. Environ Health (2012) 0.83
Urinary arsenic metabolites of subjects exposed to elevated arsenic present in coal in Shaanxi Province, China. Int J Environ Res Public Health (2011) 0.82
Influence of cobalamin on arsenic metabolism in Bangladesh. Environ Health Perspect (2009) 0.82
Differences in urinary arsenic metabolites between diabetic and non-diabetic subjects in Bangladesh. Int J Environ Res Public Health (2013) 0.82
A pilot study: the importance of inter-individual differences in inorganic arsenic metabolism for birth weight outcome. Environ Toxicol Pharmacol (2013) 0.81
Arsenic speciation analysis of urine samples from individuals living in an arsenic-contaminated area in Bangladesh. Environ Health Prev Med (2011) 0.81
Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan. Environ Health Perspect (2009) 0.80
Environmental exposure, chlorinated drinking water, and bladder cancer. World J Urol (2003) 0.80
Can folate intake reduce arsenic toxicity? Nutr Rev (2008) 0.80
Pancreatic cancer clusters and arsenic-contaminated drinking water wells in Florida. BMC Cancer (2013) 0.79
Variations in arsenic methylation capacity and oxidative DNA lesions over a 2-year period in a high arsenic-exposed population. Int Arch Occup Environ Health (2008) 0.78
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer. Chem Res Toxicol (2015) 0.78
A potential synergy between incomplete arsenic methylation capacity and demographic characteristics on the risk of hypertension: findings from a cross-sectional study in an arsenic-endemic area of inner Mongolia, China. Int J Environ Res Public Health (2015) 0.76
SLCO1B1 variants and urine arsenic metabolites in the Strong Heart Family Study. Toxicol Sci (2013) 0.76
Strain differences in arsenic-induced oxidative lesion via arsenic biomethylation between C57BL/6J and 129X1/SvJ mice. Sci Rep (2017) 0.75
Pesticide exposure and risk of bladder cancer: A meta-analysis. Oncotarget (2016) 0.75
Peripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart Study. Am J Epidemiol (2016) 0.75
Biological and behavioral factors modify urinary arsenic metabolic profiles in a U.S. population. Environ Health (2016) 0.75
Arsenic metabolism and one-carbon metabolism at low-moderate arsenic exposure: Evidence from the Strong Heart Study. Food Chem Toxicol (2017) 0.75
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med (2004) 71.08
The genome sequence of the malaria mosquito Anopheles gambiae. Science (2002) 20.36
A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59
LKB1 modulates lung cancer differentiation and metastasis. Nature (2007) 7.80
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol (2012) 7.16
American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol (2009) 6.77
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol (2003) 6.66
Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet (2012) 5.48
Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med (2005) 5.16
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res (2008) 5.05
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol (2009) 4.95
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med (2004) 4.84
American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol (2011) 4.64
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol (2006) 4.61
Emergency duties and deaths from heart disease among firefighters in the United States. N Engl J Med (2007) 4.20
Complex glycan catabolism by the human gut microbiota: the Bacteroidetes Sus-like paradigm. J Biol Chem (2009) 4.05
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2007) 3.91
Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol (2006) 3.71
Early specialty palliative care--translating data in oncology into practice. N Engl J Med (2013) 3.58
Phthalate exposure and human semen parameters. Epidemiology (2003) 3.57
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol (2010) 3.49
Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Intern Med (2012) 3.45
The role of chemotherapy at the end of life: "when is enough, enough?". JAMA (2008) 3.31
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. J Clin Oncol (2011) 3.21
Starch catabolism by a prominent human gut symbiont is directed by the recognition of amylose helices. Structure (2008) 3.02
XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol (2004) 2.93
Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med (2012) 2.92
The shortage of essential chemotherapy drugs in the United States. N Engl J Med (2011) 2.74
Palliative care and oncology partnerships in real practice. Oncology (Williston Park) (2011) 2.72
Fungal levels in the home and lower respiratory tract illnesses in the first year of life. Am J Respir Crit Care Med (2003) 2.64
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2012) 2.62
Texaco and its consultants. Int J Occup Environ Health (2005) 2.55
Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol (2007) 2.52
A comprehensive worksite cancer prevention intervention: behavior change results from a randomized controlled trial (United States). Cancer Causes Control (2002) 2.42
Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. JAMA (2004) 2.39
Acute chemical emergencies. N Engl J Med (2004) 2.38
Talking with patients about dying. N Engl J Med (2012) 2.34
Hospital mortality rates: how is palliative care taken into account? J Pain Symptom Manage (2010) 2.32
Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome. Crit Care Med (2007) 2.31
The relationship between environmental exposures to phthalates and DNA damage in human sperm using the neutral comet assay. Environ Health Perspect (2003) 2.27
Cooking frequency may enhance survival in Taiwanese elderly. Public Health Nutr (2012) 2.16
Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol (2012) 2.16
Body mass index and acute kidney injury in the acute respiratory distress syndrome. Crit Care Med (2012) 2.16
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med (2003) 2.11
Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome. Crit Care Med (2007) 2.08
Lung cancer in railroad workers exposed to diesel exhaust. Environ Health Perspect (2004) 2.06
Lung cancer and elemental carbon exposure in trucking industry workers. Environ Health Perspect (2012) 2.04
Providing pain and palliative care education internationally. J Support Oncol (2011) 2.04
Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing. J Clin Oncol (2009) 2.03
VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. J Clin Oncol (2008) 1.94
Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res (2004) 1.91
Dose-response relationship of prenatal mercury exposure and IQ: an integrative analysis of epidemiologic data. Environ Health Perspect (2007) 1.89
Heme oxygenase-1 microsatellite polymorphism and haplotypes are associated with the development of acute respiratory distress syndrome. Intensive Care Med (2009) 1.87
Cumulative exposure to lead in relation to cognitive function in older women. Environ Health Perspect (2008) 1.87
Is it time for (survivorship care) plan B? J Clin Oncol (2011) 1.84
Residential exposure to petrochemicals and the risk of leukemia: using geographic information system tools to estimate individual-level residential exposure. Am J Epidemiol (2006) 1.84
Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care (2004) 1.80
Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation (2002) 1.78
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet (2012) 1.77
Advances in microbicide vaginal rings. Antiviral Res (2010) 1.76
SPIKE$: a six-step protocol for delivering bad news about the cost of medical care. J Clin Oncol (2008) 1.76
Spatial modeling of PM10 and NO2 in the continental United States, 1985-2000. Environ Health Perspect (2009) 1.73
Fatal Loeffler's endocarditis due to hypereosinophilic syndrome. Am J Hematol (2007) 1.73
Inhibitor kappaB-alpha haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians. Crit Care Med (2007) 1.71
The association of particulate air metal concentrations with heart rate variability. Environ Health Perspect (2002) 1.71
High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines. Oncogene (2004) 1.69
The relationship between occupational metal exposure and arterial compliance. J Occup Environ Med (2015) 1.68
Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem (2010) 1.68
East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians. Chin J Cancer (2011) 1.66
Inhaled environmental combustion particles cause myocardial injury in the Wistar Kyoto rat. Toxicol Sci (2003) 1.66
Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol (2005) 1.64
Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J Biol Chem (2006) 1.64
PM2.5 metal exposures and nocturnal heart rate variability: a panel study of boilermaker construction workers. Environ Health (2008) 1.62
ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med (2011) 1.62
Role of diabetes in the development of acute respiratory distress syndrome. Crit Care Med (2013) 1.62
Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database. Endocr Relat Cancer (2013) 1.62
Effects of air pollutants on acute stroke mortality. Environ Health Perspect (2002) 1.61
BCL2 genetic variants are associated with acute kidney injury in septic shock*. Crit Care Med (2012) 1.61
Use of arsenic-induced palmoplantar hyperkeratosis and skin cancers to predict risk of subsequent internal malignancy. Am J Epidemiol (2013) 1.61
Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. J Clin Oncol (2012) 1.60
Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors. Transplantation (2004) 1.59
Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome. Crit Care Med (2007) 1.59
Informed conditioning on clinical covariates increases power in case-control association studies. PLoS Genet (2012) 1.57
Alcohol dehydrogenase 2 genotypes, maternal alcohol use, and infant outcome. J Pediatr (2002) 1.57
Lung cancer and vehicle exhaust in trucking industry workers. Environ Health Perspect (2008) 1.57
Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest (2004) 1.56
Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol Biomarkers Prev (2002) 1.54
Global gene expression profiling in whole-blood samples from individuals exposed to metal fumes. Environ Health Perspect (2005) 1.54
Genome-wide analysis of survival in early-stage non-small-cell lung cancer. J Clin Oncol (2009) 1.52
An analysis of anesthesia-controlled operating room time after propofol-based total intravenous anesthesia compared with desflurane anesthesia in ophthalmic surgery: a retrospective study. Anesth Analg (2014) 1.52
Using exposure prediction rules for exposure assessment: an example on whole-body vibration in taxi drivers. Epidemiology (2004) 1.52